References

Combining an expanded 800+ gene panel with a new dimension of epigenomic insights—15 MB of extensive methylation coverage.¹

Unrivaled discovery power with genomic and epigenomic profiling.¹

Increased accuracy in MRD and monitoring.¹

Detection of hypermethylated promoter regions.¹

MRD, minimal residual disease.

Exploratory applications.¹